Literature DB >> 1439312

[Frequency and risk factors associated with metronidazole therapeutic noncompliance].

J Garduño-Espinosa1, M C Martínez-García, A Fajardo-Gutiérrez, M Ortega-Alvarez, A Alvarez-Espinosa, V Vega-Pérez, O Muñoz-Hernández.   

Abstract

OBJECTIVE: to determine the frequency and risk factors of non-compliance to oral metronidazole. STUDY
DESIGN: comparative cross-sectional survey. STUDY UNITS: 111 patients who received oral metronidazole. SETTING CHARACTERISTICS: two medical units: one primary level unit and one secondary care unit of the Mexican Institute of Social Security. MEASUREMENTS: non-compliance was assessed by home interview and pill count. MAIN
RESULTS: frequency of non-compliance was 55%. Risk factors for non-compliance were: female sex (OR = 3.0; p less than 0.05); side effects (OR = 3.1; p less than 0.05); low literacy (OR = 3.75; p less than 0.05). Stratified analysis showed no interaction between variables.
CONCLUSIONS: frequency of non-compliance to metronidazole is high, and could affect the effectiveness of medical care. Female patients with low literacy and who suffer side effects are a high risk group for non-compliance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1439312

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  2 in total

1.  A data-driven predictive approach for drug delivery using machine learning techniques.

Authors:  Yuanyuan Li; Scott C Lenaghan; Mingjun Zhang
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

2.  Antineoplastic kinase inhibitors: A new class of potent anti-amoebic compounds.

Authors:  Conall Sauvey; Gretchen Ehrenkaufer; Da Shi; Anjan Debnath; Ruben Abagyan
Journal:  PLoS Negl Trop Dis       Date:  2021-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.